✦ LIBER ✦
4004 Cetuximab plus capecitabine as first-line treatment for elderly patients (pts) with advanced colorectal cancer (mCRC). Final analysis of activity and survival according to KRAS status – the TTD-06–01 Spanish Cooperative Group trial
✍ Scribed by F. Rivera; C. Gravalos; B. Massutí; J. Puente; E. Marcuello; M. Valladares; V. Gutiérrez; L. Layos; E. Díaz-Rubio; E. Aranda
- Book ID
- 119600496
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 48 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.